BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21925717)

  • 1. Prognostic significance of RIN1 gene expression in human non-small cell lung cancer.
    Wang Q; Gao Y; Tang Y; Ma L; Zhao M; Wang X
    Acta Histochem; 2012 Sep; 114(5):463-8. PubMed ID: 21925717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
    Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
    Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
    Yang J; Liu H; Wang H; Sun Y
    Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
    Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.
    Wang ZX; Bian HB; Wang JR; Cheng ZX; Wang KM; De W
    J Surg Oncol; 2011 Dec; 104(7):847-51. PubMed ID: 21721011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I
    Oncol Rep; 2004 Oct; 12(4):849-53. PubMed ID: 15375511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The balance of VEGF-C and VEGFR-3 mRNA is a predictor of lymph node metastasis in non-small cell lung cancer.
    Takizawa H; Kondo K; Fujino H; Kenzaki K; Miyoshi T; Sakiyama S; Tangoku A
    Br J Cancer; 2006 Jul; 95(1):75-9. PubMed ID: 16755294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
    Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
    Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Fu K; Zhang J
    Chin Med J (Engl); 2008 Mar; 121(5):445-9. PubMed ID: 18364119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I
    Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L; Mei TH; Zhou XD; Zhang XG
    Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
    Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
    Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of FoxP1 is associated with improved survival in patients with non-small cell lung cancer.
    Feng J; Zhang X; Zhu H; Wang X; Ni S; Huang J
    Am J Clin Pathol; 2012 Aug; 138(2):230-5. PubMed ID: 22904134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low RIN1 expression in HCC is associated with tumor invasion and unfavorable prognosis.
    He H; Wu G; Liu H; Cheng Y; Yu Y; Wang Y; Liu Y
    Am J Clin Pathol; 2013 Jul; 140(1):73-81. PubMed ID: 23765536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FATS expression is associated with cisplatin sensitivity in non small cell lung cancer.
    Tian Y; Zhang J; Yan S; Qiu L; Li Z
    Lung Cancer; 2012 Jun; 76(3):416-22. PubMed ID: 22137560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.